Atrial fibrillation and quality of life related to disease and treatment: focus on anticoagulation

摘要: ABSTRACT:  Anticoagulation therapy is essential to reduce the risk of stroke in patients with atrial fibrillation. Traditionally, clinical trials have focused only on determining efficacy and safety anticoagulation but not quality life. In last few years there has been a growing interest life treated oral anticoagulation. fact, specific tools that can evaluate related fibrillation developed. Vitamin K antagonists shown be effective prevention thromboembolic complications. However, use vitamin K implies changes behavior lifestyle modifications may negative impact It suggested self-monitoring international normalized ratio could improve this impact. On other hand, as new anticoagulants overcome these limitations, they anticoagulant thera...